TGFβ-signaling mediates protumorigenic changes in the tumor microenvironment (TME) and promotes epithelial-to-mesenchymal transition (EMT), both of which aid in tumor progression and invasiveness [3,4]. The gene discussed is TGFB1; the disease is neoplasm.